Search research articles
Contact Us
Filters
Showing results (71-80 of 81) with videos related to
Page
of 9
Sort By:
The Journal of Biological Chemistry
|
March 14, 1997
VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
Z Poltorak, T Cohen, R Sivan, et al.
Cancer Metastasis Reviews
|
June 1, 1996
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
G Neufeld, T Cohen, H Gitay-Goren, et al.
The Journal of Biological Chemistry
|
April 29, 1994
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors
S Tessler, P Rockwell, D Hicklin, et al.
The Journal of Biological Chemistry
|
June 23, 1995
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms
S Gengrinovitch, S M Greenberg, T Cohen, et al.
Journal of Hepatology
|
June 12, 1999
Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats
N Assy, G Spira, M Paizi, et al.
The Journal of Biological Chemistry
|
March 8, 1996
Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells
H Gitay-Goren, T Cohen, S Tessler, et al.
The Journal of Biological Chemistry
|
March 15, 1993
Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor
D Ron, R Reich, M Chedid, et al.
Biochemical and Biophysical Research Communications
|
June 8, 2001
Neuroendocrine cells along the digestive tract express neuropilin-2
T Cohen, Z Gluzman-Poltorak, A Brodzky, et al.
Oncogene
|
February 28, 2024
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
C -R Pradeep, A Zeisel, W J Köstler, et al.
Oncogene
|
April 11, 2025
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
C -R Pradeep, A Zeisel, W J Köstler, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 81) with videos related to
Sort By:
Page
of 9
The Journal of Biological Chemistry
|
March 14, 1997
VEGF145, a secreted vascular endothelial growth factor isoform that binds to extracellular matrix
Z Poltorak, T Cohen, R Sivan, et al.
Cancer Metastasis Reviews
|
June 1, 1996
Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants
G Neufeld, T Cohen, H Gitay-Goren, et al.
The Journal of Biological Chemistry
|
April 29, 1994
Heparin modulates the interaction of VEGF165 with soluble and cell associated flk-1 receptors
S Tessler, P Rockwell, D Hicklin, et al.
The Journal of Biological Chemistry
|
June 23, 1995
Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms
S Gengrinovitch, S M Greenberg, T Cohen, et al.
Journal of Hepatology
|
June 12, 1999
Effect of vascular endothelial growth factor on hepatic regenerative activity following partial hepatectomy in rats
N Assy, G Spira, M Paizi, et al.
The Journal of Biological Chemistry
|
March 8, 1996
Selective binding of VEGF121 to one of the three vascular endothelial growth factor receptors of vascular endothelial cells
H Gitay-Goren, T Cohen, S Tessler, et al.
The Journal of Biological Chemistry
|
March 15, 1993
Fibroblast growth factor receptor 4 is a high affinity receptor for both acidic and basic fibroblast growth factor but not for keratinocyte growth factor
D Ron, R Reich, M Chedid, et al.
Biochemical and Biophysical Research Communications
|
June 8, 2001
Neuroendocrine cells along the digestive tract express neuropilin-2
T Cohen, Z Gluzman-Poltorak, A Brodzky, et al.
Oncogene
|
February 28, 2024
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
C -R Pradeep, A Zeisel, W J Köstler, et al.
Oncogene
|
April 11, 2025
Correction: Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions
C -R Pradeep, A Zeisel, W J Köstler, et al.
Page
of 9